JJ, Arrowhead in gene-silencing drug deal worth up to $3.7 billion

JJ, Arrowhead in gene-silencing drug deal worth up to $3.7 billion Arrowhead develops medicines that treat diseases by targeting and silencing specific genetic material, thereby blocking the production of disease-causing proteins

No comments:

Post a Comment